不同浓度A型肉毒毒素微滴注射治疗红斑毛细血管扩张型玫瑰痤疮的随机对照研究-国际临床研究杂志-CSCIED科技核心评价数据库-手机版

不同浓度A型肉毒毒素微滴注射治疗红斑毛细血管扩张型玫瑰痤疮的随机对照研究

A randomized controlled study on the treatment of erythematous telangiectatic rosacea with different concentrations of botulinum toxin type a microdroplet injections

ES评分 0 浏览量：173 下载量：0

全文阅读下载引用收藏

DOI	10.12208/j.ijcr.20260075
刊名	国际临床研究杂志 International Journal of Clinical Research
年，卷(期)	2026, 10(2)
作者	孙瑶, 王枫荻, 张警兮,
作者单位	徐州医科大学附属医院江苏徐州
摘要	目的比较不同浓度A型肉毒毒素治疗红斑毛细血管扩张型玫瑰痤疮的临床效果。方法纳入65例红斑毛细血管扩张型玫瑰痤疮患者，随机分为高浓度组（25 U/mL）和低浓度组（12.5 U/mL），均行面部A型肉毒毒素微滴注射，58例完成研究。分别于治疗前、治疗后4周及6个月采用玫瑰痤疮标准评分系统（SGS）和视觉模拟疼痛评分（VAS）评估疗效及疼痛程度。结果治疗后4周，两组SGS评分均较治疗前显著降低（P<0.05），且高浓度组改善更明显（P<0.05）；6个月时两组SGS评分与治疗前无显著差异（P>0.05）。低浓度组VAS评分高于高浓度组（P<0.05）；两组均无严重不良反应。结论总剂量相同时，不同浓度A型肉毒毒素治疗玫瑰痤疮均安全有效，高浓度方案起效更快、疼痛更轻，远期疗效相近。
Abstract	Objective To compare the clinical effects of different concentrations of botulinum toxin type A in the treatment of erythematous telangiectatic rosacea. Methods A total of 65 patients with erythematous telangiectatic rosacea were included and randomly divided into a high-concentration group (25 U/mL) and a low-concentration group (12.5 U/mL). All patients underwent facial botulinum toxin type A microdroplet injections. 58 patients completed the study. The standard scale for rosacea (SGS) and visual analogue scale for pain (VAS) were used to evaluate the efficacy and pain level before treatment, 4 weeks after treatment, and 6 months after treatment. Results At 4 weeks after treatment, the SGS scores of both groups were significantly lower than those before treatment (P<0.05), and the improvement in the high-concentration group was more significant (P<0.05); at 6 months, there was no significant difference in the SGS scores between the two groups compared with those before treatment (P>0.05). The VAS score of the low-concentration group was higher than that of the high-concentration group (P<0.05); there were no serious adverse reactions in both groups. Conclusion At the same total dose, different concentrations of botulinum toxin type A are safe and effective in the treatment of rosacea. The high-concentration regimen takes effect faster and causes less pain, and the long-term efficacy is similar.
关键词	玫瑰痤疮；A型肉毒毒素；不同浓度；临床疗效
KeyWord	Rosacea; Botulinum toxin type A; Different concentrations; Clinical efficacy
基金项目
页码	71-73

参考文献
相关文献

[1] van Zuuren EJ. Rosacea. N Engl J Med. 2017;377(18): 1754-1764.

[2] Lewandowski, M., Swierczewska, Z., & Baranska-Rybak, W. (2022). Off-Label Use of Botulinum Toxin in Dermatology-Current State of the Art. MOLECULES.

[3] 中华医学会皮肤性病学分会玫瑰痤疮研究中心，中国医师协会皮肤科医师分会玫瑰痤疮专业组. A型肉毒毒素皮内注射治疗玫瑰痤疮持久性红斑及潮红专家共识. 《中华皮肤科杂志》.

[4] 中华医学会皮肤性病学分会玫瑰痤疮研究中心,中国医师协会皮肤科医师分会玫瑰痤疮专业委员会. 中国玫瑰痤疮诊疗指南（2021版）
[J]. 中华皮肤科杂志,2021, 54(4):279-288.

[5] Yang R, L. C, Liu W,et al. Botulinum Toxin A Alleviates Persistent Erythema and Flushing in Patients with Erythema Telangiectasia Rosacea. Dermatology and therapy 12, 10.

[6] Yeh MC, S. Y, Huang YC. Intradermal injection of botulinum toxin for erythema in rosacea: A scoping review and meta-analysis. Indian J Dermatol Venereol Leprol. 91,7.

[7] Nicholas L Mascarenhas, Z. W, Yu-Ling Chang,Anna Di Nardo. TRPV4 Mediates Mast Cell Activation in Cathelicidin-Induced Rosacea Inflammation. J Invest Dermatol 137, 4.

[8] Roshni Ramachandran, M. J. M,Tony L Yaksh. A Study and Review of Effects of Botulinum Toxins on Mast Cell Dependent and Independent Pruritus. Toxins (Basel) 10.

[9] Alsaati, A. A., Alsaadoun, D., & Almathami, A. H. (2023). The Efficacy and Safety of Botulinum Toxin A for the Treatment of Rosacea: A Systematic Review. Cureus Journal of Medical Science, 15(12), e51304.

引用本文

孙瑶, 王枫荻, 张警兮. 不同浓度A型肉毒毒素微滴注射治疗红斑毛细血管扩张型玫瑰痤疮的随机对照研究 [J]. 国际临床研究杂志. 2026; 10; (2). 71 - 73.

文献评论

相关学者

相关机构